Sanjay Dubé

Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression

Mauricio Tohen, Eduard Vieta, Joseph R. Calabrese et al. · Archives of General Psychiatry · 2003 · 910 citations

Pharmacy, Pharmacotherapy, Psychiatry +17

Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia

Anantha Shekhar, William Z. Potter, Jeffrey Lightfoot et al. · American Journal of Psychiatry · 2008 · 559 citations

Medicine, Pharmacology, Psychiatry +17

Assessing and interpreting treatment effects in longitudinal clinical trials with missing data

Craig Mallinckrodt, T.M. Sanger, Sanjay Dubé et al. · Biological Psychiatry · 2003 · 246 citations · Full text

Public Health, Biostatistics, Causal Inference +13

A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder

Michael E. Thase, S. Corya, Olawale Osuntokun et al. · The Journal of Clinical Psychiatry · 2007 · 229 citations

Pharmacy, Pharmacotherapy, Psychiatry +14

Sertraline safety and efficacy in major depression: A double-blind fixed-dose comparison with placebo

Louis F. Fabre, F.S. Abuzzahab, Mohamed Amin et al. · Biological Psychiatry · 1995 · 185 citations

Pharmacy, Pharmacology, Pharmacotherapy +16